SUMOylation and ubiquitylation of PCNA in recombination and translesion synthesis
PCNA 重组和跨损伤合成中的 SUMO 化和泛素化
基本信息
- 批准号:8707499
- 负责人:
- 金额:$ 33.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:BackBindingBinding SitesBiological AssayBypassCellsComplexDNADNA DamageDNA biosynthesisDNA replication forkDevelopmentEnzymesEventFaceFailureGenetic RecombinationGenome StabilityGenomic InstabilityHandHumanIn VitroLeadMethodologyMethodsModelingModificationMolecular ConformationMutagenesisPathway interactionsPolymerasePositioning AttributePost-Translational Protein ProcessingProcessProductionProliferating Cell Nuclear AntigenProtein BindingProtein DynamicsProteinsRecruitment ActivityRegulationRoentgen RaysShapesSlideStructureSurfaceTestingTimeUbiquitinWorkbasecarcinogenesiscopingenzyme activityflexibilityhelicasein vivoinnovationinsightmolecular dynamicsmutantnovelpreventpublic health relevancerecombinational repairreconstitutionrepairedresearch studysingle moleculetoolyeast genetics
项目摘要
DESCRIPTION (provided by applicant): Post-translational modifications of proliferating cell nuclear antigen (PCNA) are essential for maintaining genome stability. PCNA ubiquitylation facilitates translesion synthesis of damaged DNA templates, and PCNA SUMOylation prevents aberrant recombination. This proposal focuses on understanding the protein interactions regulated by post-translational modifications of PCNA and how these interactions modulate translesion synthesis and recombination. The proposed studies are possible because of a highly innovative technological development made by our group which allows for the production of large quantities of modified PCNA using a split/fusion strategy. Using this approach, we determined the X-ray crystal structures of both ubiquitin-modified PCNA (Ubi-PCNA) and SUMO-modified PCNA (SUMO-PCNA). Aim 1 is to study the interaction and regulation of target proteins by Ubi-PCNA and SUMO-PCNA. Modified PCNA will be analyzed in single-molecule binding and reconstituted enzyme assays. These studies will test the tool belt model of PCNA action. Aim 2 is to study the structure and dynamics of Ubi-PCNA and SUMO-PCNA. Structural studies will determine the dynamics of modified PCNA and test the hypothesis that dynamic protein-protein partner complexes are critical for regulation. Studies will also determine how post-translational modification of PCNA effects interactions with anti-recombinogenic helicases and modulates recombination. Aim 3 is to study the regulation of DNA synthesis and recombination by Ubi-PCNA and SUMO-PCNA. The split/fusion methodology allows expression of constitutively modified PCNA in cells. This allows in vivo analysis of the effects of ubiquitylated and SUMOylated PCNA. These studies will provide a clear understanding of exactly how PCNA recruits proteins to replication forks, how the activities of different proteins bound to PCNA are regulated and coordinated, how the hand-off between different proteins occurs on PCNA during multi-step processes, and how post-translational modifications of PCNA have such different effects on these processes.
描述(由申请人提供):增殖细胞核抗原(PCNA)的翻译后修饰对于维持基因组稳定性至关重要。PCNA泛素化促进损伤DNA模板的跨损伤合成,PCNA SUMO化防止异常重组。该建议的重点是了解蛋白质的相互作用调节的PCNA的翻译后修饰,以及这些相互作用如何调节translesion合成和重组。所提出的研究是可能的,因为我们的小组进行了高度创新的技术开发,允许使用分裂/融合策略生产大量的修饰的PCNA。利用这种方法,我们确定了泛素修饰的PCNA(Ubi-PCNA)和SUMO修饰的PCNA(SUMO-PCNA)的X射线晶体结构。目的1研究Ubi-PCNA和SUMO-PCNA对靶蛋白的相互作用及调控。将在单分子结合和重组酶测定中分析修饰的PCNA。这些研究将测试PCNA作用的工具带模型。目的2研究Ubi-PCNA和SUMO-PCNA的结构和动态变化。结构研究将确定修改后的PCNA的动力学和测试的假设,动态蛋白质-蛋白质伴侣复合物的监管是至关重要的。研究还将确定PCNA的翻译后修饰如何影响与抗重组解旋酶的相互作用并调节重组。目的3研究Ubi-PCNA和SUMO-PCNA对DNA合成和重组的调控。分裂/融合方法允许组成型修饰的PCNA在细胞中表达。这允许在体内分析泛素化和SUMO化的PCNA的作用。这些研究将提供一个清晰的理解,究竟如何PCNA招募蛋白质复制叉,如何与PCNA结合的不同蛋白质的活动进行调节和协调,如何在多步骤过程中发生在PCNA不同蛋白质之间的交接,以及如何翻译后修饰的PCNA有这些过程中的不同影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. TODD WASHINGTON其他文献
M. TODD WASHINGTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. TODD WASHINGTON', 18)}}的其他基金
Structural and Mechanistic Studies of DNA Damage Bypass Pathways in Eukaryotes
真核生物 DNA 损伤旁路途径的结构和机制研究
- 批准号:
10551662 - 财政年份:2023
- 资助金额:
$ 33.27万 - 项目类别:
SUMOylation and ubiquitylation of PCNA in recombination and translesion synthesis
PCNA 重组和跨损伤合成中的 SUMO 化和泛素化
- 批准号:
9040207 - 财政年份:2013
- 资助金额:
$ 33.27万 - 项目类别:
SUMOylation and ubiquitylation of PCNA in recombination and translesion synthesis
PCNA 重组和跨损伤合成中的 SUMO 化和泛素化
- 批准号:
8580606 - 财政年份:2013
- 资助金额:
$ 33.27万 - 项目类别:
Mechanisms of damaged DNA replication in eukaryotes
真核生物 DNA 复制受损的机制
- 批准号:
7917120 - 财政年份:2009
- 资助金额:
$ 33.27万 - 项目类别:
Mechanisms of damaged DNA replication in eukaryotes
真核生物 DNA 复制受损的机制
- 批准号:
7870328 - 财政年份:2008
- 资助金额:
$ 33.27万 - 项目类别:
Mechanisms of Damaged DNA Replication in Eukaryotes
真核生物中受损 DNA 复制的机制
- 批准号:
10004053 - 财政年份:2008
- 资助金额:
$ 33.27万 - 项目类别:
Mechanisms of damaged DNA replication in eukaryotes
真核生物 DNA 复制受损的机制
- 批准号:
8092859 - 财政年份:2008
- 资助金额:
$ 33.27万 - 项目类别:
Mechanisms of damaged DNA replication in eukaryotes
真核生物 DNA 复制受损的机制
- 批准号:
8299078 - 财政年份:2008
- 资助金额:
$ 33.27万 - 项目类别:
Mechanisms of damaged DNA replication in eukaryotes
真核生物 DNA 复制受损的机制
- 批准号:
9297313 - 财政年份:2008
- 资助金额:
$ 33.27万 - 项目类别:
Mechanisms of damaged DNA replication in eukaryotes
真核生物 DNA 复制受损的机制
- 批准号:
7530654 - 财政年份:2008
- 资助金额:
$ 33.27万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 33.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 33.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 33.27万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 33.27万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 33.27万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 33.27万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 33.27万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 33.27万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 33.27万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 33.27万 - 项目类别:
Standard Grant